Skip to main content

Long-Term Fate of the Hepatocyte Hyperplastic Foci Induced by a Two Stage Carcinogenetic Protocol

  • Chapter
Chemical Carcinogenesis

Abstract

The appearance of a liver hepatocellular neoplasm is always preceded by the development of histochemically detectable hepatocyte focal lesions (HFL) which are believed to be related to the development of hepatoma (for recent reviews: Bannasch1, Moore and Kitagawa2, Farber and Sarma3). A large discrepancy, however, usually exists between the number of HFL and the number of tumors per liver. Since initiation is thought as an irreversible step in the natural history of neoplasia and HFL are considered a cell population derived from initiated hepatocytes4, HFL as such should be stable in time, i.e. they should not disappear after withdrawal of the inducing carcinogen(s). This has been actually observed in some models of liver carcinogenesis5–7. In others, however, many of the HFL present at the end of the carcinogen administration cycle seem to disappear with time8–10.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. P. Bannasch, Preneoplastic lesions as end points in carcinogenicity testing, l, Hepatic preneoplasia, Carcinogenesis 7:698 (1986).

    Google Scholar 

  2. M. A. Moore and T. Kitagawa, Hepatocarcinogenesis in the rat: The effect of promoters and carcinogens in vivo and in vitro, Int. Rev. Cytol. 101:125 (1986).

    Article  PubMed  CAS  Google Scholar 

  3. E. Farber and D. S. R. Sarma, Biology of disease, Hepatocarcinogenesis: a dynamic cellular perspective, Lab. Invest. 56:A (1987).

    Google Scholar 

  4. D. B. Solt, E. Cayama, D. S. R. Sarma and E. Farber, Persistence of resistant putative preneoplastic hepatocytes induced by N-Nitrosodiethylamine or N-methyl-N-nitrosourea, Cancer Res. 40:1112 (1980).

    PubMed  CAS  Google Scholar 

  5. E. Scherer, M. Hoffmann, P. Emmelot and M. Friedrich-Freksa, Quantitative study on foci of altered liver cells induced in the rat by a single dose of diethylnitrosamine and partial hepatectomy, J. Natl. Cancer Inst. 49:93 (1972).

    PubMed  CAS  Google Scholar 

  6. A. M. Moore, D. Mayer and P. Bannasch, The dose dependence and sequential appearance of putative preneoplastic populations induced in the rat liver by stop experiments with N-nitrosomorpholine, Carcinogenesis 3:1429 (1982).

    Article  PubMed  CAS  Google Scholar 

  7. T. Goldsworthy, M. A. Campbell and M. C. Pitot, The natural history and dose response characteristics of enzyme altered foci in rat liver following phenobarbital and diethylnitrosamine administration, Carcinogenesis 5:67 (1984).

    Article  PubMed  CAS  Google Scholar 

  8. G. M. Williams and K. Watanabe, Quantitative kinetics of development of N-2 fluorenylecetamide-induced altered hyperplastic hepatocellular foci resistant to iron accumulation and of the reversion or persistence following removal of carcinogen, J. Natl. Cancer Inst. 61:113 (1978).

    PubMed  CAS  Google Scholar 

  9. M. Tatematsu, Y. Nagamine and E. Farber, Redifferentiation as a basis for remodeling of carcinogen induced hepatocytes nodules to normal appearing liver, Cancer Res. 43:5049 (1983).

    PubMed  CAS  Google Scholar 

  10. K. Enomoto and E. Farber, Kinetics of phenotypic maturation or remodeling of hyperplastic nodules during liver carcinogenesis, Cancer Res. 42:2330 (1982).

    PubMed  CAS  Google Scholar 

  11. G. Malvaldi, E. Chieli and M. Saviozzi, Promotive effects of thiobenzamide on liver carcinogenesis, Gann 74:469 (1983).

    PubMed  CAS  Google Scholar 

  12. G. Malvaldi, E. Chieli and M. Saviozzi, Characterization of the promoting activity of Thiobenzamide on liver carcinogenesis, Toxicol. Pathol. 14:370 (1986).

    Article  PubMed  CAS  Google Scholar 

  13. N. Hirota and G. M. Williams, The sensitivity and heterogeneity of histochemical markers for altered foci involved in liver carcinogenesis, Anu. J. Pathol. 95:317 (1979).

    CAS  Google Scholar 

  14. A. M. Rutenburg, M. Kim, J. W. Fischbein, J. S. Hanker, H. L. Wasserkrug and A. M. Seligman, Histochemical and ultrastructural demonstration of gamma glutamyltranspeptidase activity, J. Histochem. Cytochem. 17:517 (1969).

    Article  PubMed  CAS  Google Scholar 

  15. M. A. Campbell, H. C. Pitot, V. R. Potter and B. A. Laishes, Application of quantitative stereology to the evaluation of enzyme altered foci in rat liver, Cancer Res. 41:465 (1982).

    Google Scholar 

  16. T. D. V. Swinscow, “Statistics at square one”, British Medical Association, London (1978).

    Google Scholar 

  17. M. A. Moore, M. J. Hacker and P. Bannasch, Phenotypic instability in focal and nodular lesions induced in a short-term system in the rat liver, Carcinogenesis 4:595 (1983).

    Article  PubMed  CAS  Google Scholar 

  18. M. Tatematsu, T. Takano, R. Hasegawa, K. Imaida, J. Nakanowatari and N. Ito, A sequential quantitative study of the reversibility or irreversibility of liver hyperplastic nodules in rats exposed to hepatocarcinogens, Gann 71:483 (1980).

    Google Scholar 

  19. A. Columbano, G. M. Ledda-Columbano, P. M. Rao, S. Rajalakshmi and D. S. R. Sarma, Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells, Am. J. Pathol. 116:441 (1984).

    PubMed  CAS  Google Scholar 

  20. W. Bursch, B. Lauer, I. Timmermann-Troisiener, G. Barthel, J. Schuppler and R. Schulte-Hermann, Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters, Carcinogenesis 5:453 (1984).

    Article  PubMed  CAS  Google Scholar 

  21. A. H. Wyllie, J. F. R. Kerr and A. R. Currie, Cell death: the significance of apoptosis, Int. Rev. Cytol. 68:251 (1980).

    Article  PubMed  CAS  Google Scholar 

  22. R. G. Cameron, K. Imaida, H. Tsuda and H. Ito, Promotive effects of steroids and bile acids on hepatocarcinogenesis initiated by diethylnitrosamine, Cancer Res. 42:2426 (1982).

    PubMed  CAS  Google Scholar 

  23. C. Peraino, E. F. Staffeldt, B. A. Carnes, V. A. Ludeman, J. A. Blomquist and S. V. Vesselinovitch, Characterization of histochemically detectable altered hepatocyte foci and their relationship to hepatic tumorigenesis in rats treated once with diethylnitrosamine or Benzo(a)-pyrene withine one day after birth, Cancer Res. 44:3340 (1984).

    PubMed  CAS  Google Scholar 

  24. T. L. Goldsworthy and H. C. Pitot, The quantitative analysis and stability of histochemical markers of altered hepatic foci in rat liver following initiation by diethylnitrosamine administration and promotion with phenobarbital, Carcinogenesis 6:1261 (1985).

    Article  PubMed  CAS  Google Scholar 

  25. M. D. Estadella, M. J. Pujol and J. Domingo, Enzyme pattern and growth rate of liver preneoplastic clones during carcinogenesis by diethylnitrosamine, Oncology 41:276 (1984).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer Science+Business Media New York

About this chapter

Cite this chapter

Malvaldi, G., Chieli, E., Marradi, A., Saviozzi, M. (1988). Long-Term Fate of the Hepatocyte Hyperplastic Foci Induced by a Two Stage Carcinogenetic Protocol. In: Feo, F., Pani, P., Columbano, A., Garcea, R. (eds) Chemical Carcinogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9640-7_29

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9640-7_29

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9642-1

  • Online ISBN: 978-1-4757-9640-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics